Reply to Tiruvoipati et al.: VENT-AVOID Trial: Avoiding Acute Hypercapnic Respiratory Failure!
- PMID: 38608271
- PMCID: PMC11208957
- DOI: 10.1164/rccm.202403-0618LE
Reply to Tiruvoipati et al.: VENT-AVOID Trial: Avoiding Acute Hypercapnic Respiratory Failure!
Comment on
-
VENT-AVOID Trial: Avoiding Acute Hypercapnic Respiratory Failure!Am J Respir Crit Care Med. 2024 Jun 15;209(12):1513-1514. doi: 10.1164/rccm.202403-0514LE. Am J Respir Crit Care Med. 2024. PMID: 38608272 Free PMC article. No abstract available.
References
-
- Duggal A, Conrad SA, Barrett NA, Saad M, Cheema T, Pannu S, et al. VENT-AVOID Investigators Extracorporeal carbon dioxide removal to avoid invasive ventilation during exacerbations of chronic obstructive pulmonary disease: VENT-AVOID Trial — a randomized clinical trial. Am J Respir Crit Care Med . 2024;209:529–542. - PubMed
-
- Venkatesan P. GOLD COPD report: 2024 update. Lancet Respir Med . 2024;12:15–16. - PubMed
-
- Morelli A, Del Sorbo L, Pesenti A, Ranieri VM, Fan E. Extracorporeal carbon dioxide removal (ECCO2R) in patients with acute respiratory failure. Intensive Care Med . 2017;43:519–530. - PubMed
-
- Omecinski K, Cove M, Duggal A, Federspiel W. Extracorporeal carbon dioxide removal (ECCO2R): a contemporary review. Appl Eng Sci . 2022;10:100095.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical